At present, limited studies have been carried out regarding the effect of topical preparations of finastride for androgenic alopecia. In the current study an approach to enhance follicular delivery of drug by the Niosomal gel formulation will be investigated.
Primary Aim:
To prepare topical niosomal gel of Finastride for enhancing the drug concentration to androgn receptors (type II 5 alpha reductase recepors ) in the hair shaft of androgenic alopecia patients.
Secondary Aims:
To improve patient compliance with reduced dose of finastride in niosomal form.
Current Status
Studies almost finished and soon it will b published .
Studies almost finished and soon it will b published .